CC

Ca-a Cancer Journal For Clinicians

CA: A Cancer Journal for Clinicians is the flagship journal of the American Cancer Society and reaches oncology specialists, primary care clinicians, and other professionals who interact with patients with cancer. It publishes information about the prevention, early detection, and treatment of cancer, as well as nutrition, palliative care, survivorship, and related topics in cancer care. The journal also accepts proposals for high-impact randomized trials that inform standards of care.

Looking to publish in Ca-a Cancer Journal For Clinicians? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology
Impact Factor 232.4
Quartile Q1
Open Access Type Hybrid
ISSN 0007-9235
eISSN 1542-4863
Invitation Only Yes
Cost Range No submission, page, or color fees. Accepted papers are published under a CC-BY-NC-ND Creative Commons license at no charge to the author; an Article Publication Charge applies if authors require a license other than CC-BY-NC-ND.

Submission Instructions

Ca-a Cancer Journal For Clinicians is an invitation-only journal. Submissions are accepted by invitation from the editorial board only. The following article types are accepted:

Review Articles

Cover Letter A cover letter is required. Cover letter must describe the significance of the work, verify the originality of the work, and disclose any previous abstracts, presentations, reports, or publications that might overlap with the submission, along with any additional information that may impact review.
Abstract An abstract is required. Abstract must be 250 words or fewer.
Manuscript Review Articles should be 7000 to 10000 words, including references and tables. Main text file must include 3 to 7 keywords.
References Style must follow AMA Manual of Style, 11th edition. References must be numbered sequentially in the order cited, not alphabetized, with all authors listed for six or fewer authors and the first three authors followed by "et al" for seven or more authors.
Figures & Tables Tables must be included in the main text file, while figures must be supplied as separate files. Figure legends must be provided in the main text file, and all tables and figures must be cited consecutively in the text using Arabic numerals.
Reformat to Ca-a Cancer Journal For Clinicians using Livewrite Premium

Phase Iii Randomized Trials

Cover Letter A cover letter is required. Cover letter must describe the significance of the work, verify its originality, disclose any previous abstracts, presentations, reports, or publications that might overlap, and include any additional information that may affect review.
Abstract An abstract is required. Abstract must be 250 words or less.
Manuscript Phase III Randomized Trials must report prospective high-impact randomized trials. Main text file must include 3-7 MeSH keywords, funding and conflict of interest statements, acknowledgments, references, tables, figure legends, and the total counts of words, tables, figures, and supplementary files.
References References must follow AMA style, 11th edition. References must be numbered sequentially in order of citation rather than alphabetized, with all authors listed for six or fewer authors and the first three followed by et al. for seven or more authors.
Figures & Tables Tables must be included in the main text file, while figures must be supplied as separate files and not embedded in the manuscript. Each table must have a title and footnotes, and figure legends must be provided on a separate page in the main text file.
Reformat to Ca-a Cancer Journal For Clinicians using Livewrite Premium

Perspectives: Research In Context

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Manuscript requirements are not specified.
References References must follow AMA Manual of Style, 11th edition, and be numbered sequentially in the order cited rather than alphabetized. References must be numbered manually in citation order, list all authors when there are six or fewer, list the first three authors followed by "et al" when there are seven or more, and exclude personal communications, unpublished observations, and submitted manuscripts.
Figures & Tables Tables must be included in the main text file, and figures must be supplied as separate files rather than embedded in the manuscript. Figure legends must be provided on a separate page, and tables must be editable, numbered consecutively, and understandable without reference to the text.
Reformat to Ca-a Cancer Journal For Clinicians using Livewrite Premium

Virtual Tumor Board

Cover Letter A cover letter is required. The cover letter must describe the significance of the work, verify its originality, disclose any previous abstracts, presentations, reports, or publications that may overlap with the submission, and include any additional information that may affect review.
Abstract An abstract is required. Abstract must be 250 words or fewer.
Manuscript The main text file must include a short informative title without abbreviations, a running title under 40 characters, 3 to 7 MeSH keywords, the total word count, counts of tables, figures, and supplementary files, references, figure legends, tables, acknowledgments, funding, and a conflict of interest statement.
References References must follow AMA Manual of Style, 11th edition. References must be numbered sequentially in the order cited rather than alphabetized, list all authors when there are six or fewer and the first three followed by et al when there are seven or more, and exclude personal communications, unpublished observations, and submitted manuscripts.
Figures & Tables Tables must be included in the main text file, while figures must be supplied as separate files and not embedded in word processing documents. Tables must be numbered consecutively and be self-contained with titles and footnotes, and figure legends must be provided on a separate page with concise descriptions and definitions of symbols, abbreviations, and units.
Reformat to Ca-a Cancer Journal For Clinicians using Livewrite Premium

Recent Publications

Twenty‐year results of the randomized European Organization for Research and Treatment of Cancer trial 22922/10925 evaluating internal mammary chain and medial supraclavicular lymph node irradiation in stage I–III breast cancer

Orit Kaidar‐Person, Caroline G. Weltens, Catherine Fortpied, Luc J. E. E. Scheijmans, Carine Y. Kirkove, Volker Budach, Karine Peignaux‐Casasnovas, Mariacarla Valli, Max Peters, Femke van der Leij, Sofia Rivera, Nicola Weidner, Desirée H. J. G. van den Bongard, Claudia Linsenmeier, Roxolyana Abdah‐Bortnyak, Shaymaa Hosni, Eveline Koiter, Antoine M. Engelen, Adinda Baten, Lydia Champezou, Alain Fourquet, Harry G. M. M. Bartelink, Henk Struikmans, Philip M. P. Poortmans

10.3322/caac.70082
View Publication

Long‐term follow‐up after regional nodal irradiation: What wisdom comes with age

Youssef H. Zeidan, Stephen A. Mihalcik, Rachel B. Jimenez

10.3322/caac.70089
View Publication

Issue Information

-

10.3322/caac.70068
View Publication

Medullary thyroid carcinoma and RET molecular testing: A virtual tumor board on clinical decision‐making

Lucas Kallas‐Silva, Victor Alexandre dos Santos Valsecchi, Ana O. Hoff, Evelin Cavalcante Farias, Rui Monteiro de Barros Maciel, Rachel Riera, Laura Sterian Ward, Lucas Leite Cunha

10.3322/caac.70086
View Publication

Adding carboplatin to sequential taxane–anthracycline neoadjuvant chemotherapy shows improved event‐free and overall survival benefits in premenopausal women with triple‐negative breast cancer

Carrie Printz

10.3322/caac.70077
View Publication

Frequently asked questions

How long does it take to publish?

Is a cover letter required?

A cover letter is required. It should describe the significance of the work, verify originality, disclose previous abstracts, presentations, reports, or publications with overlapping material, include any additional information relevant to review, and be addressed to the Editor, Dr. Don S. Dizon.

Reformat to Ca-a Cancer Journal For Clinicians using Livewrite Premium

What are the publication costs?

Research Topics

Advances in Oncology and Radiotherapy Global Cancer Incidence and Screening Cancer Treatment and Pharmacology BRCA gene mutations in cancer Economic and Financial Impacts of Cancer Cancer survivorship and care Breast Cancer Treatment Studies Colorectal Cancer Screening and Detection Childhood Cancer Survivors' Quality of Life Advanced Breast Cancer Therapies Nutrition, Genetics, and Disease Palliative Care and End-of-Life Issues Medical Research and Treatments Head and Neck Cancer Studies Cancer Risks and Factors Cervical Cancer and HPV Research Multiple and Secondary Primary Cancers Genetic factors in colorectal cancer Lung Cancer Treatments and Mutations Cancer Genomics and Diagnostics Cancer Diagnosis and Treatment Nutrition and Health in Aging Colorectal and Anal Carcinomas Gastric Cancer Management and Outcomes Cutaneous Melanoma Detection and Management

Related Journals

CI
Clinical Implant Dentistry And Related Research WILEY
JO
Journal Of Esthetic And Restorative Dentistry WILEY
P2
Periodontology 2000 WILEY
BJ
British Journal Of Haematology WILEY
CD
Cancer Discovery American Association for Cancer Research
CR
Critical Reviews In Oncology Hematology Elsevier BV